Suppr超能文献

用于基于mRNA、miRNA和DNA甲基化的体液鉴定的共提取试剂盒的评估

Evaluation of a co-extraction kit for mRNA, miRNA and DNA methylation-based body fluid identification.

作者信息

Watanabe Ken, Akutsu Tomoko

机构信息

National Research Institute of Police Science, Chiba 277-0882, Japan.

National Research Institute of Police Science, Chiba 277-0882, Japan.

出版信息

Leg Med (Tokyo). 2020 Feb;42:101630. doi: 10.1016/j.legalmed.2019.101630. Epub 2019 Nov 11.

Abstract

Recently, messenger RNA (mRNA), micro RNA (miRNA), and DNA methylation (DNAm) have been reported as novel markers for body fluid identification (BFID). Comprehensive analysis of these markers should be a flexible and reliable BFID method for various types of forensic samples. However, independent extraction of all targets can be difficult depending on the usable amounts of samples. In this study, the applicability of a co-extraction kit for these molecules, the AllPrep DNA/RNA/miRNA Universal Kit (APU), was evaluated by comparing RNA and DNA extracted from blood and saliva stains by the APU with those extracted by standard kits for each molecule and by previously reported methods for mRNA/DNA or miRNA/DNA co-extraction. Electrophoresis using the Bioanalyzer platform and real-time PCR analysis revealed that the APU performed almost equivalently to each standard kit in the quality of RNA or DNA extracted and extraction efficiency of mRNAs, miRNAs, and DNA. Moreover, the APU outperformed the co-extraction methods, especially in RNA integrity and miRNA extraction efficiency. In addition, pyrosequencing revealed that the methylation ratios of DNA extracted by the APU were not different from those extracted by standard DNA extraction kits. Overall, the APU is applicable to comprehensive analysis of mRNA/miRNA/DNAm markers for BFID analysis. Because the DNA eluate can also be used for DNA typing, the APU may be among the best choices for forensic examination of body fluid samples in terms of its flexibility and reliability in BFID and efficiency in sample consumption.

摘要

最近,信使核糖核酸(mRNA)、微小核糖核酸(miRNA)和DNA甲基化(DNAm)已被报道为体液鉴定(BFID)的新型标志物。对这些标志物进行综合分析应是一种适用于各类法医样本的灵活且可靠的BFID方法。然而,根据样本的可用量,独立提取所有目标物可能会很困难。在本研究中,通过将使用AllPrep DNA/RNA/miRNA通用试剂盒(APU)从血渍和唾液斑中提取的RNA和DNA,与使用各分子的标准试剂盒以及先前报道的mRNA/DNA或miRNA/DNA共提取方法提取的RNA和DNA进行比较,评估了该用于这些分子的共提取试剂盒APU的适用性。使用生物分析仪平台进行的电泳和实时PCR分析表明,APU在提取的RNA或DNA质量以及mRNA、miRNA和DNA的提取效率方面,与每个标准试剂盒的表现几乎相当。此外,APU的表现优于共提取方法,尤其是在RNA完整性和miRNA提取效率方面。此外,焦磷酸测序显示,APU提取的DNA的甲基化率与标准DNA提取试剂盒提取的DNA的甲基化率没有差异。总体而言,APU适用于对BFID分析的mRNA/miRNA/DNAm标志物进行综合分析。由于DNA洗脱液也可用于DNA分型,就其在BFID中的灵活性和可靠性以及样本消耗效率而言,APU可能是法医体液样本检验的最佳选择之一。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验